Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Ehlers-Danlos Syndromes (EDS) : Fiona Li Pharm D Candidate University of Saint Joseph School of Pharmacy

Download as pdf or txt
Download as pdf or txt
You are on page 1of 22

Ehlers-Danlos Syndromes(EDS)

Fiona Li
Pharm D Candidate
University of Saint Joseph
School of Pharmacy
Objectives

Describe common manifestations and


pathophysiology of Ehlers-Danlos Syndrome

Discuss current treatment & management


options
Patient Background

 22 year old female

 Chief Complaint: Severe right lower quadrant


pain, with vomiting

 Past Medical History:


Ehlers-Danlos Syndrome
Recurrent urinary tract infections
Patient Background(Cont.)

Social History: Marijuana use, smoking

Allergy: No known allergies

No remarkable lab results


Patient Medication
Home medication Hospital medication
Pantoprazole 40mg PO qDay Pantoprazole 40mg IV push BID
Hydromorphone 2mg q4hr prn Hydromorphone 1-2mg IV once
Medroxyprogesterone q90days Senna 8.6mg po BID
Diazepam 5mg QID, prn Lorazepam 1mg IV push q4h
Docusate 100mg po BID
Ketorolac 30mg IV once
Ceftriaxone 1gm IV q24h for 4 days
Levofloxacin 750mg po q24hr for 8d
Ondansetron 4mg IV once
Promethazine 25mg IV once prn
Tamsulosin 0.4mg po qday
Acetaminophen 650mg po q4h prn
Continuous infusions NSS 1000ml
Ehlers-Danlos Syndrome(EDS)
Hereditary connective tissue disorder (autosomal
dominant or recessive traits)
Prevalence: 1/10000 to 1/25000
20,000-50,000 EDS patients in the US
Signs/Symptoms
Joint hypermobility
Skin hyperextensibility
Tissue fragility
Pain
Aly Abayazeed, Vascular type Ehlers-Danlos syndrome with fatal spontaneous rupture of a right common iliac artery
dissection: case report and review of literature. J Radiol Case Rep.2014 Feb;8(2):63-69.
Signs & Symptoms
vEDS

https://www.google.com/search?q=ehlers&biw=801&bih=811&source=lnms&tbm=isch&sa=X&ei=bls1VfrzD8alNoXwgKgP&ved=0CAgQ_AUoAw#tbm=isch&q=e
Classification Of EDS
Six subtypes of EDS
Classical
Vascular
Hypermobility
Kyphoscoliotic
Arthrochalasia
Dermatosparaxis

Aly Abayazeed, Vascular type Ehlers-Danlos syndrome with fatal spontaneous rupture of a right common iliac artery dissection: case
report and review of literature. J Radiol Case Rep.2014 Feb;8(2):63-69.
Jakob Burcharth,Jacob Rosenberg, Gastrointestinal surgery and related complications
in patients with Ehlers-Danlos syndrome:A systematic review, Dig Surg 2012;29:349-357.
Vascular Type Of EDS

Vascular type EDS, 5% of all EDS cases


Deficiency of collagen type III
Decreased/absent collagen synthesis or
abnormalities in collagen secretion
Poor prognosis
Most severe subtype
Life threatening vascular ruptures
Aneurysm formation
Aly Abayazeed, Vascular type Ehlers-Danlos syndrome with fatal spontaneous rupture of a right common iliac artery dissection: case report
and review of literature. J Radiol Case Rep.2014 Feb;8(2):63-69.
EDS Diagnosis
Classification and diagnosis of EDS is difficult
Diagnosis
Clinical symptoms: Beighton Score,
Brighton/Villefranche criteria
Laboratory studies
Qualitative and quantitative testing of
collagen subtypes
Genetic mutation analysis
Positive family history
Jakob Burcharth,Jacob Rosenberg, Gastrointestinal surgery and related complications in patients with Ehlers-Danlos syndrome:A systematic
review, Dig Surg 2012;29:349-357.
https://www.google.com/search?q=ehlers&biw=801&bih=811&source=lnms&tbm=isch&sa=X&ei=bls1VfrzD8alNoXwgKgP&ved=0CAgQ_AUoAw
https://www.google.com/search?q=brighton+criteria&biw=1600&bih=837&tbm=isch&imgil=uA4I-rvyVPNe9M%253A%253BGnc3YhGvGc4kdM%253Bhttp%25253A%25252F%25252Fjaoa.org%25252Farticle.aspx%25253Farticleid%2525253D2093276&source=iu&pf=m&fir=uA4I -
http://www.bing.com/images/search?q=willefranche+criteria+&view=detailv2&id=A4E24D324E13213A98B2A02A7199B93CDE73D8E9&ccid=O6tQzHTF&simid=608020249839668791&thid=JN.JPPNn7U8onSyZtPnYskdhw&first=1&selectedindex=3
EDS Management
Patient education
Prevention and early recognition of
injuries/complications
Monitoring & Interventions
Particular manifestations
Complications with each forms of EDS
Medical alert device
No medical treatments

Susan P Pauker, Joan Stoler. Clinical manifestations and diagnosis of Ehlers-Danlos syndromes. Uptodate, Mar 2015.
EDS Management-Joint Protection
Principle of management:
Optimize function, relieve symptoms, and prevent
injury
Joint protection and function
Preserve and protect joint function
Prevent recurrent joint dislocations, chronic joint
pain and early onset of osteoarthritis
Swimming, walking, and taichi
Vitamin C 500 mg daily
Avoid carrying items weighing> 5 lbs
Susan P Pauker, Joan Stoler. Clinical manifestations and diagnosis of Ehlers-Danlos syndromes. Uptodate, Mar 2015.
EDS Management-Pain Management
Chronic musculoskeletal pain, resembles
fibromyalgia
Associated with joint damage, with neuropathic
features
Acetaminophen
NSAIDs (avoid in patient with easy bruising)
Opioid medications (controversial)
Ice on the joints
Meditation/relaxation techniques
Claudia Celletti,Marco Castori. Evaluation of Kinesiophobia and Its Correlations with Pain and Fatigue in Joint Hypermobility
Syndrome/Ehlers-Danlos Syndrome Hypermobility type. Biomed Res Int. 2013; Jul 14
Ballantyne JC, MaoJ. Opioid therapy for chronic pain. N Engl J Med. 2003 Nov 13;349(20:1943-53)
EDS Management-Skin Fragility/Bruising

Protective bandages/pads over exposed


areas
Avoid heavy exercise, contact sports
Avoid aspirin, NSAIDs, anticoagulants
Recommend Vitamin C, 1-4 g daily in adults,
it shows decrease bruising and improve
wound healing

Susan P Pauker, Joan Stoler. Clinical manifestations and diagnosis of Ehlers-Danlos


syndromes. Uptodate, Mar 2015.
EDS Management-Bleeding Disorders
Vasopressin analogue, desmopressin (DDAVP)
Tranexamic acid
Recombinant FVIIa
Avoid drugs that interfere with hemostatic
process(ASA, NSAIDs, anticoagulants)
Avoid invasive vascular procedures whenever
possible
Ultrasound guidance if it is unavoidable to
central venous catheterization
Thomas wilesmann, Marco Castori. Recommendations for anesthesia and perioperative management in patients
with Ehlers-Danlos syndrome. Orphanet J Rare Dis. 2014;9:109
Monitoring
Non-invasive monitoring
Cardiovascular disease
Ophthalmology
Spine disease
Individualized depending on the
severity of disease and specific
manifestations , tailored to the type
of EDS
http://www.bing.com/images/search?q=Ehlers-
Danlos%20spinal&qs=n&form=QBIR&pq=ehlers-
danlos%20spinal&sc=8-20&sp=-1&sk=

Thomas wilesmann, Marco Castori. Recommendations for anesthesia and perioperative management in patients
with Ehlers-Danlos syndrome. Orphanet J Rare Dis. 2014;9:109
Patient Case
Pain management
Hydromorphone 1-2 mg IV q4hr
Ketorolac 30 mg IV once
Acetaminophen 650 mg po q4hr prn
Lorazepam 1 mg IV push q4hr
Ice on joints

You might also like